Constitutive expression and involvement of cyclooxygenase-2 in human megakaryocytopoiesis

被引:29
作者
Tanaka, N [1 ]
Sato, T [1 ]
Fujita, H [1 ]
Morita, I [1 ]
机构
[1] Tokyo Med & Dent Univ, Dept Cellular Physiol Chem, Grad Sch, Bunkyo Ku, Tokyo 1138549, Japan
关键词
megakaryocytopoiesis; cyclooxygenase-1; cyclooxygenase-2; platelets; thromboxane A(2);
D O I
10.1161/01.ATV.0000117181.68309.10
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective - Cyclooxygenase-1 (COX-1), but not COX-2, is expressed in human platelets, and thromboxane A(2) (TXA(2)) produced via COX-1 induces platelet aggregation. The objectives of this study were to investigate the expression of COX-1 and COX-2 during platelet differentiation and to determine whether these enzymes are involved in the differentiation. Methods and Results - CD34(+) progenitor cells isolated from human cord blood were cultured with thrombopoietin and c-kit ligand. The cells differentiated into megakaryocytes (CD34(-)/CD41(+)) after 8 days of culture and into platelets (CD41(+)/prodium iodide(-)) after 14 days of culture. The CD34(+) cells expressed a trace of COX-1 gene and no COX-2 gene. On day 5, COX-2 gene expression was observed and continued throughout the remainder of the culture. COX-1 gene expression increased after 8 days of culture. The treatment of this liquid culture with indomethacin, a dual inhibitor of COX-1 and COX-2, and NS-398, a COX-2 - specific inhibitor, suppressed megakaryocyte differentiation. In contrast, at a dose of 10(-7) M, mofezolac, which is a highly selective inhibitor of COX-1, did not affect differentiation. NS-398 - induced suppression of megakaryocyte differentiation was partly abrogated by stable analogues of TXA2. Conclusions - We report here that COX-2 and COX-1 are constitutively expressed in megakaryocytes, and TXA2 produced by COX-2 plays an important role in megakaryocytopoiesis.
引用
收藏
页码:607 / 612
页数:6
相关论文
共 47 条
[1]   SELECTIVE GROWTH-RESPONSE TO IL-3 OF A HUMAN-LEUKEMIC CELL-LINE WITH MEGAKARYOBLASTIC FEATURES [J].
AVANZI, GC ;
LISTA, P ;
GIOVINAZZO, B ;
MINIERO, R ;
SAGLIO, G ;
BENETTON, G ;
CODA, R ;
CATTORETTI, G ;
PEGORARO, L .
BRITISH JOURNAL OF HAEMATOLOGY, 1988, 69 (03) :359-366
[2]   Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. [J].
Bombardier, C ;
Laine, L ;
Reicin, A ;
Shapiro, D ;
Burgos-Vargas, R ;
Davis, B ;
Day, R ;
Ferraz, MB ;
Hawkey, CJ ;
Hochberg, MC ;
Kvien, TK ;
Schnitzer, TJ ;
Weaver, A .
NEW ENGLAND JOURNAL OF MEDICINE, 2000, 343 (21) :1520-1528
[3]   THROMBOPOIETIN (C-MPL LIGAND) ACTS SYNERGISTICALLY WITH ERYTHROPOIETIN, STEM-CELL FACTOR, AND INTERLEUKIN-11 TO ENHANCE MURINE MEGAKARYOCYTE COLONY GROWTH AND INCREASES MEGAKARYOCYTE PLOIDY IN-VITRO [J].
BROUDY, VC ;
LIN, NL ;
KAUSHANSKY, K .
BLOOD, 1995, 85 (07) :1719-1726
[4]  
CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2
[5]   Differential suppression of thromboxane biosynthesis by indobufen and aspirin in patients with unstable angina [J].
Cipollone, F ;
Patrignani, P ;
Greco, A ;
Panara, MR ;
Padovano, R ;
Cuccurullo, F ;
Patrono, C ;
Rebuzzi, AG ;
Liuzzo, G ;
Quaranta, G ;
Maseri, A .
CIRCULATION, 1997, 96 (04) :1109-1116
[6]   Characterization of a bipotent erythro-megakaryocytic progenitor in human bone marrow [J].
Debili, N ;
Coulombel, L ;
Croisille, L ;
Katz, A ;
Guichard, J ;
BretonGorius, J ;
Vainchenker, W .
BLOOD, 1996, 88 (04) :1284-1296
[7]   Characterization of a partial prostaglandin endoperoxide a synthase-1 deficiency in a patient with a bleeding disorder [J].
Dubé, JN ;
Drouin, J ;
Aminian, M ;
Plant, MH ;
Laneuville, O .
BRITISH JOURNAL OF HAEMATOLOGY, 2001, 113 (04) :878-885
[8]   Aspirin-resistant thromboxane biosynthesis and the risk of myocardial infarction, stroke, or cardiovascular death in patients at high risk for cardiovascular events [J].
Eikelboom, JW ;
Hirsh, J ;
Weitz, JI ;
Johnston, M ;
Yi, Q ;
Yusuf, S .
CIRCULATION, 2002, 105 (14) :1650-1655
[9]   NS-398, A NEW ANTIINFLAMMATORY AGENT, SELECTIVELY INHIBITS PROSTAGLANDIN-G/H SYNTHASE CYCLOOXYGENASE (COX-2) ACTIVITY IN-VITRO [J].
FUTAKI, N ;
TAKAHASHI, S ;
YOKOYAMA, M ;
ARAI, I ;
HIGUCHI, S ;
OTOMO, S .
PROSTAGLANDINS, 1994, 47 (01) :55-59
[10]   Role of NF-κB in the antiproliferative effect of endothelin-1 and tumor necrosis factor-α in human hepatic stellate cells -: Involvement of cyclooxygenase-2 [J].
Gallois, C ;
Habib, A ;
Tao, JC ;
Moulin, S ;
Maclouf, J ;
Mallat, A ;
Lotersztajn, S .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (36) :23183-23190